Gabapentin misuse, abuse and diversion: a systematic review
about
Medication Overuse in Chronic Pain.Psychoactive medications and disengagement from office based opioid treatment (obot) with buprenorphine.Law enforcement-derived data on gabapentin diversion and misuse, 2002-2015: diversion rates and qualitative research findings.Providing chronic pain management in the "Fifth Vital Sign" Era: Historical and treatment perspectives on a modern-day medical dilemma.A New Tool to Tackle the Opioid Epidemic: Description, Utility, and Results from the Maine Diversion Alert Program.Risk to heroin users of polydrug use of pregabalin or gabapentin.Prevalence of Gabapentin Abuse: Comparison with Agents with Known Abuse Potential in a Commercially Insured US Population.Analgesic use by ageing and elderly patients with chronic non-malignant pain: a qualitative study.Gabapentin, opioids, and the risk of opioid-related death: A population-based nested case-control study.A novel non-opioid protocol for medically supervised opioid withdrawal and transition to antagonist treatment.All-Cause and Drug-Related Medical Events Associated with Overuse of Gabapentin and/or Opioid Medications: A Retrospective Cohort Analysis of a Commercially Insured US Population.Advances in Pharmacotherapy Development: Human Clinical Studies.Gabapentin for the treatment of alcohol use disorder.A Qualitative Analysis of Gabapentin Misuse and Diversion Among People Who Use Drugs in Appalachian Kentucky.The extent that health professionals suspect and address addiction to medicines in primary care: Findings from a survey in Northwest England.Commentary on Smith et al. (2016): Gabapentin-looks like a drug that can be misused…, probably is a drug that can be misused.Misuse of gabapentin and pregabalin: a marker for a more serious malaise?Oxycodone-induced tolerance to respiratory depression: reversal by ethanol, pregabalin and protein kinase C inhibition.Therapeutic potential of medicinal marijuana: an educational primer for health care professionals.
P2860
Q30238960-E78E342F-5A6D-4AD7-892E-D348F5904FCAQ36198525-700CE6AF-4B68-41A9-8C04-B068BFF13509Q36368798-1318631F-C896-4511-9A70-740AFF37897DQ38737065-63EB3CD0-D1D5-4FD2-806A-CB5BEF1F7186Q38764593-CE368F71-ADF4-4148-AFAE-5C5FA8560990Q38792361-F35B6AFC-09EA-4B80-86AC-0DF125BE08E6Q38815468-A9C4EA2F-28AB-49D4-9702-5989D846D579Q41223230-67B9A677-60B8-4E9A-8962-49BB98900084Q42369450-6BB6039A-9C21-499F-AD4F-D1C0F0EB0667Q43061611-83095051-9025-4E06-9AAB-3C6699D0AD78Q44349264-E9B7DEED-EA4C-44E0-9A7D-E203E98BA736Q47182010-C44100C3-B36C-46DC-BE40-3B27FFB27007Q47309377-26D61412-C692-435E-B7C2-DCEFC872951BQ47654027-0E80E361-1DF8-4670-84A0-4F9FB04439FBQ47752508-5E603EF0-DFBC-40A3-B646-29304C33AECCQ52309749-BF45661D-EE91-467A-AF31-1679A60A5811Q52310183-D4A6FB38-FDE9-4BBB-9F4A-27D75F569C4AQ54119525-8D8CF2A1-569D-49DE-859E-4DDD02051CCAQ55397242-F3BA22CC-58C4-42DF-AA10-0FF4AB124B87
P2860
Gabapentin misuse, abuse and diversion: a systematic review
description
2016 nî lūn-bûn
@nan
2016 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
name
Gabapentin misuse, abuse and diversion: a systematic review
@ast
Gabapentin misuse, abuse and diversion: a systematic review
@en
type
label
Gabapentin misuse, abuse and diversion: a systematic review
@ast
Gabapentin misuse, abuse and diversion: a systematic review
@en
prefLabel
Gabapentin misuse, abuse and diversion: a systematic review
@ast
Gabapentin misuse, abuse and diversion: a systematic review
@en
P2093
P2860
P356
P1433
P1476
Gabapentin misuse, abuse and diversion: a systematic review
@en
P2093
Jennifer R Havens
Rachel V Smith
Sharon L Walsh
P2860
P304
P356
10.1111/ADD.13324
P407
P577
2016-01-27T00:00:00Z